»ó´Ü¿©¹é
±â»ç (Àüü 407°Ç)
[Expert Opinion] Çѱ¹ÀÎ ÀÌ»óÁöÁúÇ÷Áõ ¸ÂÃãÄ¡·á ±Ù°Å·Î ±â´ë THE MOST 2020-10-12 17:32
[Interview] ¡°ASCVD ¿¹¹æ¡¤°ü¸®, Áß¼ºÁö¹æµµ ÇÙ½ÉÀÎÀÚ´Ù¡± ÀÓ¼¼Çü ±âÀÚ 2020-10-12 16:10
[Sub Story] ³úÁ¹Áß °ü¸®, Ä¡¸Å¿¹¹æ¿¡ ´ëÇÑ ¡®½ÇÇö °¡´ÉÇÑ¡¯ Àü·« ÀÓ¼¼Çü ±âÀÚ 2020-08-13 16:12
[Sub Story] ¡°Çѱ¹ÀÎ AMI Ä¡·áÀü·«, ¡®È®½Å¡¯°¡Áö°í Àû¿ëÇÒ ¼ö ÀÖ´Â ±â¹Ý ´ÙÁ³´Ù¡± ÀÓ¼¼Çü ±âÀÚ 2020-08-13 16:10
[Cover Story] Çѱ¹Àο¡°Ô ¸Â´Â ½É³úÇ÷°üÁúȯ ¡®ÆÛÁñ¡¯ ¸ÂÃç°£´Ù ÀÓ¼¼Çü ±âÀÚ 2020-08-13 16:09
¶óÀÎ
[Sub Story]
[Çѱ¹ÀΠȯÀÚ¿¡¼­ Àú¡¤Áß°­µµ ½ºÅ¸Æ¾]

±âÀúÄ¡ ´ëºñ LDL-C 50% ÀÌ»ó °¨¼Ò°¡ ÀûÇÕ

¸ñÇ¥¼öÄ¡ µµ´Þ ÈÄ Àú¡¤Áß°­µµ ½ºÅ¸Æ¾À¸·Î À¯Áö °í·Á

THE MOST 2020-08-13 15:45
[Drug Review] Ç÷´ç¡¤ÄÝ·¹½ºÅ×·Ñ µ¿½Ã°ø·« ¼øÀÀµµ ÀÌ»ó¹« ÀÌ»óµ· ±âÀÚ 2020-07-25 14:24
[Drug Review] Á¦¹Ì·Î¿ì, ¡®ìéà´ß²ð衯 Ä¡·áÀü·«À¸·Î ºÎ°¢ ÀÓ¼¼Çü ±âÀÚ 2020-07-19 18:51
[Sub Story] ´ë»çÁõÈıº °øÆ÷´Â ½ÇÈ­ ÀÓ¼¼Çü ±âÀÚ 2020-07-19 15:10
[Sub Story] ´ç´¢º´ ȯÀÚ, ½ºÅ¸Æ¾ Ä¡·á ±Ù°Å ÀÖ³ª? ÀÌ»óµ· ±âÀÚ 2020-07-19 15:04
¶óÀÎ
[Interview] ¡°ÇÇŸ¹Ù½ºÅ¸Æ¾À¸·Î

Ç÷°ü¡¤´ë»ç ÇýÅà ¸ðµÎ ÀâÀ» ¼ö À־

ÀÌ»óµ· ±âÀÚ 2020-07-19 14:44
[Sub Story] ¿¡Á¦Æ¼¹Ìºê Ãß°¡ÇýÅà ºÃ´õ´Ï¡¦ ÀÌ»óµ· ±âÀÚ 2020-07-19 14:35
[Sub Story] ÀÎŬ¸®½Ã¶õ,

¡®Â÷¼¼´ë¡¯ ÀÌ»óÁöÁúÇ÷Áõ Ä¡·áÁ¦·Î ´ëµÎ

ÇãÈñÀ± ±âÀÚ 2020-07-19 14:27
[Sub Story] °íTG¡¤ÀúHDL-C º°µµ Àü·« ÀÖ¾î¾ß ÀÌ»óµ· ±âÀÚ 2020-07-19 14:23
[Sub Story] ½ºÅ¸Æ¾+Æä³ëÇǺ극ÀÌÆ® ÀÜ¿© ½ÉÇ÷°ü À§Çè¡é ÀÓ¼¼Çü ±âÀÚ 2020-07-19 14:16
¶óÀÎ
[Sub Story] üÁß°¨¼Ò ³Ñ¾î ½ÉÇ÷°ü ÇýÅñîÁö ÀÓ¼¼Çü ±âÀÚ 2020-07-19 11:01
[Late Breaking Studies] û¼Ò³â ºñ¸¸¡¤´ç´¢º´, Ç÷°ü³ëÈ­·Î À̾îÁø´Ù ÀÓ¼¼Çü ±âÀÚ 2020-07-17 17:12
[Conference Report] °ü»óµ¿¸ÆÁúȯ¿¡ ´ç´¢º´ µ¿¹Ý, Ä¡·á ¾î¶»°Ô? ÀÓ¼¼Çü ±âÀÚ 2020-06-03 13:32
[Cover Story]

LDLÄÝ·¹½ºÅ×·Ñ ¸ñǥġ

À¯·´½ÉÀåÇÐȸ vs Çѱ¹ÁöÁúµ¿¸Æ°æÈ­ÇÐȸ

ÀÌ»óµ· ±âÀÚ 2020-05-14 10:57
[Sub Story] ¼­±¸È­µÈ Çѱ¹ ¡°LDL-C Á¶Àý¿¡ ÁýÁßÇÒ ¶§¡± ÀÌ»óµ· ±âÀÚ 2020-05-14 10:38
Back to Top